1. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway. (25th December 2020) Authors: Yang, Xinxiu; Gao, Meng; Miao, Mengqi; Jiang, Cuihua; Zhang, Dongjian; Yin, Zhiqi; Ni, Yicheng; Chen, Jing; Zhang, Jian Journal: Journal of pharmacy and pharmacology Issue: Volume 73:Number 2(2021) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗